Summary | |
---|---|
Symbol | LRRTM1 |
Name | leucine rich repeat transmembrane neuronal 1 |
Aliases | FLJ32082; leucine-rich repeat transmembrane neuronal 1 protein; Leucine-rich repeat transmembrane neuronal p ...... |
Chromosomal Location | 2p12 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Basic function annotation. > Subcellular Location, Domain and Function > Gene Ontology > KEGG and Reactome Pathway |
Subcellular Location | Cell membrane Single-pass type I membrane protein Cell junction, synapse, postsynaptic cell membrane Single-pass type I membrane protein |
Domain |
PF13855 Leucine rich repeat |
Function |
Exhibits strong synaptogenic activity, restricted to excitatory presynaptic differentiation, acting at both pre- and postsynaptic level. |
Biological Process |
GO:0001933 negative regulation of protein phosphorylation GO:0002090 regulation of receptor internalization GO:0002091 negative regulation of receptor internalization GO:0006469 negative regulation of protein kinase activity GO:0006898 receptor-mediated endocytosis GO:0007259 JAK-STAT cascade GO:0007416 synapse assembly GO:0007626 locomotory behavior GO:0030100 regulation of endocytosis GO:0031623 receptor internalization GO:0033673 negative regulation of kinase activity GO:0035418 protein localization to synapse GO:0035640 exploration behavior GO:0042326 negative regulation of phosphorylation GO:0043112 receptor metabolic process GO:0044089 positive regulation of cellular component biogenesis GO:0044708 single-organism behavior GO:0045806 negative regulation of endocytosis GO:0046425 regulation of JAK-STAT cascade GO:0046426 negative regulation of JAK-STAT cascade GO:0048167 regulation of synaptic plasticity GO:0048259 regulation of receptor-mediated endocytosis GO:0048261 negative regulation of receptor-mediated endocytosis GO:0050803 regulation of synapse structure or activity GO:0050804 modulation of synaptic transmission GO:0050806 positive regulation of synaptic transmission GO:0050807 regulation of synapse organization GO:0050808 synapse organization GO:0051051 negative regulation of transport GO:0051348 negative regulation of transferase activity GO:0051962 positive regulation of nervous system development GO:0051963 regulation of synapse assembly GO:0051965 positive regulation of synapse assembly GO:0060291 long-term synaptic potentiation GO:0060627 regulation of vesicle-mediated transport GO:0097696 STAT cascade GO:1902532 negative regulation of intracellular signal transduction GO:1904892 regulation of STAT cascade GO:1904893 negative regulation of STAT cascade |
Molecular Function |
GO:0004857 enzyme inhibitor activity GO:0004860 protein kinase inhibitor activity GO:0019207 kinase regulator activity GO:0019210 kinase inhibitor activity GO:0019887 protein kinase regulator activity |
Cellular Component |
GO:0030424 axon GO:0030426 growth cone GO:0030427 site of polarized growth GO:0045211 postsynaptic membrane GO:0060076 excitatory synapse GO:0097060 synaptic membrane GO:0098794 postsynapse |
KEGG | - |
Reactome |
R-HSA-6794361: Interactions of neurexins and neuroligins at synapses R-HSA-112316: Neuronal System R-HSA-6794362: Protein-protein interactions at synapses |
Summary | |
---|---|
Symbol | LRRTM1 |
Name | leucine rich repeat transmembrane neuronal 1 |
Aliases | FLJ32082; leucine-rich repeat transmembrane neuronal 1 protein; Leucine-rich repeat transmembrane neuronal p ...... |
Chromosomal Location | 2p12 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Literatures that report relations between LRRTM1 and anti-tumor immunity. The specific mechanism were also collected if the literature reports that a gene specifically promotes or inhibits the infiltration or function of T/NK cells. |
There is no record. |
Summary | |
---|---|
Symbol | LRRTM1 |
Name | leucine rich repeat transmembrane neuronal 1 |
Aliases | FLJ32082; leucine-rich repeat transmembrane neuronal 1 protein; Leucine-rich repeat transmembrane neuronal p ...... |
Chromosomal Location | 2p12 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | High-throughput screening data (e.g. CRISPR-Cas9, shRNA and RNAi) for T cell-mediated killing. Genetic screen techniques can identify mechanisms of tumor cell resistance (e.g., PTPN2) and sensitivity (e.g., APLNR) to killing by cytotoxic T cells, the central effectors of anti-tumor immunity. After comprehensively searching, eight groups of screening data sets were collected in the current database. In this tab, users can check whether their selected genes cause resistance or increase sensitivity to T cell-mediated killing in various data sets. |
> High-throughput Screening
[ TOP ]
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Statistical results of LRRTM1 in screening data sets for detecting immune reponses.
|
Summary | |
---|---|
Symbol | LRRTM1 |
Name | leucine rich repeat transmembrane neuronal 1 |
Aliases | FLJ32082; leucine-rich repeat transmembrane neuronal 1 protein; Leucine-rich repeat transmembrane neuronal p ...... |
Chromosomal Location | 2p12 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Transcriptomic and genomic profiling of pre-treated tumor biopsies from responders and non-responders to immunotherapy. These data were used to identify signatures and mechanisms of response to checkpoint blockade (e.g., anti-PDL1 and anti-PD1). One example is that mutations in the gene PBRM1 benefit clinical survival of patients with clear cell renal cell carcinoma. After comprehensively searching, we collected 5 and 6 of transcriptomic and genomic data sets, respectively. In this tab, users can check whether their selected genes have significant difference of expression or mutation between responders and non-responders in various data sets. > Expression difference between responders and non-responders > Mutation difference between responders and non-responders |
Points in the above scatter plot represent the expression difference of LRRTM1 in various data sets.
|
Points in the above scatter plot represent the mutation difference of LRRTM1 in various data sets.
|
Summary | |
---|---|
Symbol | LRRTM1 |
Name | leucine rich repeat transmembrane neuronal 1 |
Aliases | FLJ32082; leucine-rich repeat transmembrane neuronal 1 protein; Leucine-rich repeat transmembrane neuronal p ...... |
Chromosomal Location | 2p12 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between abundance of tumor-infiltrating lymphocytes (TILs) and expression, copy number, methylation, or mutation of LRRTM1. The immune-related signatures of 28 TIL types from Charoentong's study, which can be viewed in the download page. For each cancer type, the relative abundance of TILs were inferred by using gene set variation analysis (GSVA) based on gene expression profile. In this tab, users can examine which kinds of TILs might be regulated by the current gene. |
Summary | |
---|---|
Symbol | LRRTM1 |
Name | leucine rich repeat transmembrane neuronal 1 |
Aliases | FLJ32082; leucine-rich repeat transmembrane neuronal 1 protein; Leucine-rich repeat transmembrane neuronal p ...... |
Chromosomal Location | 2p12 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between three kinds of immunomodulators and expression, copy number, methylation, or mutation of LRRTM1. These immunomo-dulators were collected from Charoentong's study. In this tab, users can examine which immunomodulators might be regulated by LRRTM1. > Immunoinhibitor > Immunostimulator > MHC molecule |
Summary | |
---|---|
Symbol | LRRTM1 |
Name | leucine rich repeat transmembrane neuronal 1 |
Aliases | FLJ32082; leucine-rich repeat transmembrane neuronal 1 protein; Leucine-rich repeat transmembrane neuronal p ...... |
Chromosomal Location | 2p12 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Relations between chemokines (or receptors) and expression, copy number, methylation, or mutation of LRRTM1. In this tab, users can examine which chemokines (or receptors) might be regulated by the current gene. > Chemokine > Receptor |
Summary | |
---|---|
Symbol | LRRTM1 |
Name | leucine rich repeat transmembrane neuronal 1 |
Aliases | FLJ32082; leucine-rich repeat transmembrane neuronal 1 protein; Leucine-rich repeat transmembrane neuronal p ...... |
Chromosomal Location | 2p12 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Distribution of LRRTM1 expression across immune and molecular subtypes. > Immune subtype > Molecular subtype |
Summary | |
---|---|
Symbol | LRRTM1 |
Name | leucine rich repeat transmembrane neuronal 1 |
Aliases | FLJ32082; leucine-rich repeat transmembrane neuronal 1 protein; Leucine-rich repeat transmembrane neuronal p ...... |
Chromosomal Location | 2p12 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content |
Associations between LRRTM1 and clinical features. > Overall survival analysis > Cancer stage > Tumor grade |
Summary | |
---|---|
Symbol | LRRTM1 |
Name | leucine rich repeat transmembrane neuronal 1 |
Aliases | FLJ32082; leucine-rich repeat transmembrane neuronal 1 protein; Leucine-rich repeat transmembrane neuronal p ...... |
Chromosomal Location | 2p12 |
External Links | HGNC, NCBI, Ensembl, Uniprot, GeneCards |
Content | Drugs targeting LRRTM1 collected from DrugBank database. |
There is no record. |